Professional Documents
Culture Documents
Dicloxacillin 5-Methyl-3-(2,6- DYNAPEN The substitution of chlorine atoms on both Its medicinal properties and use are the
dichlorophenyl)-4- PATHOCIL carbons ortho to the position of attachment of the same as those of cloxacillin sodium.
isoxazolylpenicillin VERACILLIN phenyl ring to the isoxazole ring is presumed to
[3-(2,6-dichlorophenyl)-5-
enhance further the stability of the oxacillin
methyl-4 isoxazolyl] penicillin
sodium monohydrate
congener dicloxacillin sodium
Ampicillin D--Aminobenzylpenicillin PENBRITN This product is active against the same Gram- It may be used to treat infections caused
6-[D- POLYCILLIN positive organisms that are susceptible to other by Gram-negative bacilli for which a
-aminophenylacetamido] OMNIPEN penicillins, and it is more active against some broad-spectrum antibiotic, such as a
penicillanic acid AMCILL
Gram-negative bacteria and enterococci than are tetracycline or chloramphenicol, may be
PRINCIPEN
other penicillins. indicated but not preferred because of
D-(-)-Ampicillin, prepared from D-(-) - amino undesirable reactions or lack of
phenylacetic acid, is significantly more active than bactericidal effect.
L-(+)-ampicillin. It is particularly useful for the treatment
Ampicillin is not resistant to penicillinase, and it of acute urinary tract infections caused by
produces the allergic reactions and other E. coli or Proteus mirabilis and is the
untoward effects found in penicillin-sensitive agent of choice against Haemophilus
patients. influenzae infections. Ampicillin, together
with probenecid, to inhibit its active
tubular excretion, has become a
treatment of choice for gonorrhea in
recent years.
Amoxicillin D- -Amino- AMOXIL Semisynthetic penicillin introduced in 1974, is Amoxicillin has largely replaced ampicillin
phydroxybenzylpenicillin LAROTID simply the p-hydroxy analog of ampicillin, for the treatment of certain systemic and
POLYMOX prepared by acylation of 6-APA with urinary tract infections for which oral
phydroxyphenylglycine. administration is desirable. Amoxicillin is
Its antibacterial spectrum is nearly identical with reportedly less effective than ampicillin in
that of ampicillin, and like ampicillin, it is resistant the treatment of
to acid, susceptible to alkaline and -lactamase bacillary dysentery, presumably because
hydrolysis, and weakly protein bound. of its greater GI absorption.
Amoxicillin is a fine, white to off-white, crystalline
powder that is sparingly soluble in water. It is
available in various oral dosage forms. Aqueous
suspensions are stable for 1 week at room
temperature.
Carbenicillin Carboxybenzylpenicillin GEOPEN Semisynthetic penicillin released in the United Carbenicillin has been effective in the
Disodium, Sterile disodium PYOPEN States in 1970. Carbenicillin is not stable in acids treatment of systemic & urinary tract
and is inactivated by penicillinase. It is a malonic infections caused by P. aeruginosa,
acid derivative and, as such, decarboxylates indole-producing Proteus spp., and
readily to penicillin G, which is acid labile. Providencia spp., all of which are
Solutions of the disodium salt should be freshly resistant to ampicillin. Most clinicians
prepared but, when refrigerated, may be kept for 2 prefer to use a combination of
weeks. It must be administered by injection and is carbenicillin and gentamicin for serious
usually given intravenously. pseudomonal and mixed coliform
infections. The 2 antibiotics are
chemically incompatible, however, and
should never be combined in an
intravenous solution.
Carbenicillin 5-indanyl ester carbenicillin GEOCILLIN Indanyl carbenicillin occurs as the sodium salt, an Indanyl carbenicillin provides an orally
Indanyl Sodium indanyl, 6-[2-phenyl-2-(5- off-white, bitter powder that is freely soluble in active alternative for the treatment of
indanyloxycarbonyl)acetamido water. It is stable in acid. It should be protected carbenicillin-sensitive systemic and
]penicillanic acid
from moisture to prevent hydrolysis of the ester. urinary tract infections caused by
Pseudomonas spp., indole-positive
Clinical trials with indanyl carbenicillin revealed a Proteus spp., and selected species of
relatively high frequency of GI symptoms (nausea, Gram-negative bacilli.
occasional vomiting, and diarrhea). It seems
doubtful that the high doses required for the
treatment of serious systemic infections could be
tolerated by most patients.
Ticarcillin -Carboxy-3-thienylpenicillin TICAR This semisynthetic penicillin derivative, like Greater in vitro potency against several
Disodium, Sterile carbenicillin, is unstable in acid and, therefore, species of Gramnegative bacilli, most
must be administered parenterally. It is similar to notably P. aeruginosa and Bacteroides
carbenicillin in antibacterial spectrum and fragilis. These advantages can be crucial
pharmacokinetic properties. in the treatment of serious infections
Ticarcillin has slightly better pharmacokinetic requiring high-dose therapy.
properties, including higher serum levels and a
longer duration of action
Piperacillin -(4-Ethyl-2,3-dioxo-1- PIPRACIL Piperacillin is destroyed rapidly by stomach acid; Is the most generally useful of the
piperazinylcarbonylamino) therefore, it is active only by intramuscular or extended- spectrum acylureidopenicillins.
benzylpenicillin intravenous administration. The injectable form is It is more active than mezlocillin against
provided as the white, crystalline, water-soluble susceptible strains of Gram-negative
sodium salt. Its pharmacokinetic properties are aerobic bacilli, such as Serratia
very similar to those of the other marcescens, Proteus, Enterobacter,
acylureidopenicillins. Citrobacter spp., and P. aeruginosa.
Mezlocillin -(1-Methanesulfonyl-2- MEZLIN an acylureidopenicillin with an antibacterial It is much more active against most
Sodium, Sterile oxoimidazolidinocarbonylamin spectrum similar to that of carbenicillin and Klebsiella spp., P. aeruginosa, anaerobic
o) benzylpenicillin ticarcillin; however, there are some major bacteria (e.g., Streptococcus faecalis and
differences. B. fragilis), and H. influenzae. It is
It is available as a white, crystalline, water-soluble recommended for the treatment of serious
sodium salt for injection. Solutions should be infections caused by these organisms.
prepared freshly and, if not used within 24 hours,
refrigerated.
CATEGORY Generic Name Chemical Name OTHER Description R Group or Uses
NAMES Structure
-LACTAMASE Clavulanate 1-oxopenam lacking the amoxicillin + K Clavulanic acid is an antibiotic isolated from Combinations of amoxicillin and the
Potassium 6-acylamino side chain of salts of Streptomyces clavuligeris. potassium salts of clavulanic acid are
INHIBITORS
penicillins but possessing a 2- clavulanic available (Augmentin) in various fixed-
Because these
hydroxyethylidene moiety at
inhibitors are also acid Clavulanic acid is acid-stable. It cannot undergo dose oral dosage forms intended for the
C-2.
substrates AUGMENTIN penicillanic acid formation because it lacks an treatment of skin, respiratory, ear, and
for the enzymes that amide side chain. urinary tract infections caused by
they inactivate, they -lactamaseproducing bacterial strains.
are sometimes Ticarcillin These combinations are effective against
Referred to as Disodium + K -lactamaseproducing strains of S.
suicide substrates. clavulanate aureus, E. coli, K. pneumoniae,
TIMENTIN Enterobacter, H. influenzae, Moraxella
catarrhalis, and Haemophilus ducreyi,
which are resistant to amoxicillin alone.
The combination contains 3 g of ticarcillin
disodium and 100 mg of potassium
clavulanate in a sterile powder for
injection (Timentin).This combination has
been recommended for septicemia, lower
respiratory tract infections, and urinary
tract infections caused by - lactamase
producing Klebsiella spp., E. coli, P.
aeruginosa, and other Pseudomonas
spp., Citrobacter spp., Enterobacter spp.,
S. marcescens, and S. aureus. It also is
used in bone and joint infections caused
by these organisms.
Sulbactam penicillanic acid sulfone or Ampicillin This synthetic penicillin derivative is a potent Fixed-dose combinations of ampicillin
1,1-dioxopenicillanic acid. sodium + inhibitor of S. aureus -lactamase sodium and sulbactam sodium, marketed
sulbactam Sulbactam has weak intrinsic antibacterial activity under the trade name Unasyn as sterile
sodium but potentiates the activity of ampicillin and powders for injection, have been
UNASYN approved for use in the United States.
carbenicillin against -lactamaseproducing
These combinations are recommended
S. aureus and members of the
for the treatment of skin, tissue, intra-
Enterobacteriaceae family.
abdominal, and gynecological infections
caused by _-lactamaseproducing strains
of S. aureus, E. coli, Klebsiella spp., P.
mirabilis, B. fragilis, and Enterobacter and
Acinetobacter spp.
Tazobactam piperacillin Is a penicillanic acid sulfone that is similar in Approved indications for the combination
sodium + structure to sulbactam. It is a more potent include the treatment of appendicitis,
tazobactam lactamase inhibitor than sulbactam and has a postpartum endometritis, and pelvic
sodium slightly broader spectrum of activity than inflammatory disease caused by
ZOSYN clavulanic acid. It has very weak antibacterial -lactamaseproducing E. coli and
activity. Tazobactam is available in fixed-dose, Bacteroides spp., skin & skin structure
injectable combinations with piperacillin, infections caused by -lactamase
producing S. aureus, and pneumonia
caused by -lactamaseproducing
strains of H. influenzae.
CARBAPENEMS
Thienamycin A novel -lactam antibiotic first isolated and It is highly active against most aerobic
identified by researchers at Merck from and anaerobic Gram-positive and
fermentation of cultures of Streptomyces cattleya. Gramnegative bacteria, including S.
Thienamycin displays outstanding broad-spectrum aureus, P. aeruginosa, and B. fragilis.
antibacterial properties in vitro. Furthermore, it is resistant to inactivation
by most -lactamases elaborated by
An unfortunate property of thienamycin is its Gram-negative and Grampositive bacteria
chemical instability in solution. It is more and, therefore, is effective against many
susceptible to hydrolysis in both acidic and strains resistant to penicillins and
cephalosporins.
alkaline solutions than most -lactam antibiotics,
because of the strained nature of its fused ring
system containing an endocyclic double bond.
Imipenem N-formimidoylthienamycin imipenem The most successful of a series of chemically Imipenem is indicated for the treatment of
Cilastatin cilastatin stable derivatives of thienamycin in which the a wide variety of bacterial infections of the
combination primary amino group is converted to a skin and tissues, lower respiratory tract,
PRIMAXIN nonnucleophilic basic function. bones and joints, and genitourinary tract,
Imipenem retains the extraordinary broad- as well as of septicemia and endocarditis
spectrum antibacterial properties of thienamycin. caused by -lactamaseproducing
Imipenem is effective against non -lactamase- strains of susceptible bacteria. These
producing strains of these and additional bacterial include aerobic Gram positive organisms
species, but other less expensive and equally such as S. aureus, Staphylococcus
effective antibiotics are preferred for the treatment epidermidis, enterococci, and viridans
of infections caused by these organisms. streptococci; aerobic Gram negative
The imipenemcilastatin combination (Primaxin) bacteria such as E. coli, Klebsiella,
is marketed as a sterile powder intended for the Serratia, Providencia, Haemophilus,
preparation of solutions for intravenous infusion. Citrobacter, and indole-positive Proteus
Such solutions are stable for 4 hours at 25C and spp., Morganella morganii, Acinetobacter
up to 24 hours when refrigerated. The and Enterobacter spp., and P. aeruginosa
concomitant administration of imipenem and an and anaerobes such as B. fragilis and
aminoglycoside antibiotic results in synergistic Clostridium, Peptococcus,
antibacterial activity in vivo. The two types of Peptidostreptococcus, Eubacterium, and
antibiotics are, however, chemically incompatible Fusobacterium spp. Some Pseudomonas
and should never be combined in the same spp. are resistant, such as P. maltophilia
intravenous bottle. and P. cepacia, as are some methicillin-
resistant staphylococci.
NEWER CARBAPENEMS
Meropenem MERREM Meropenem is a second-generation carbapenem It has recently been approved as Merrem
that, to date has undergone the most extensive for the treatment of infections caused by
clinical evaluation. Meropenem exhibits greater multiply-resistant bacteria and for
potency against Gram-negative and anaerobic empirical therapy for serious infections,
bacteria than does imipenem, but it is slightly such as bacterial meningitis, septicemia,
less active against most Gram-positive species. It pneumonia, and peritonitis
is not effective against MRSA. The lower
incidence of nephrotoxicity of meropenem
(compared with imipenem) has been correlated
with its greater stability to DHP-I and the absence
of the DHP-I inhibitor cilastatin in the preparation.
Meropenem appearsto be less epileptogenic than
imipenem when the two agents are used in the
treatment of bacterial meningitis.
Biapenem Is a newer second-generation carbapenem with It has broad-spectrum antibacterial
chemical and microbiological properties similar to activity that includes most aerobic Gram-
those of meropenem. negative and Grampositive bacteria and
It is claimed to be less susceptible to metallo- anaerobes
-lactamases than either imipenem or meropenem.
It is not active orally.
CATEGORY GENERIC NAME CHEMICAL NAME OTHER NAMES DESCRIPTION STRUCTURE USES
CEPHALOSPORINS Cephalexin 7-(D-amino- KEFLEX 1st generation Because of minimal protein binding and
phenylacetamido)-3- KEFORAL
-lactam antibiotics ROA: Oral nearly exclusive renal excretion,
methylcephemcarboxylic Acid resistant: Yes cephalexin is recommended particularly
isolated from
acid
Cephalosporium spp. Plasma Protein Binding: 5-15% for the treatment of urinary tract
or prepared B-Lactamase Resistance: Poor infections. It is also sometimes used for
semisynthetically Spectrum of activity: Broad upper respiratory tract infections.
Antipseudomonal Activity: No
Cephalexin occurs as a white crystalline
monohydrate. It is freely soluble in water, resistant
to acid and absorbed well orally. Food does not
interfere with its absorption.
Its spectrum of activity is very similar to those of
cephalothin and cephaloridine.
Cephalexin is somewhat less potent than these
two agents after parenteral administration and,
therefore, is inferior to them for the treatment of
serious systemic infections.
Cephradine ANSPOR 1st generation It is recommended for the treatment of
VELOSEF ROA: Oral, Parenteral uncomplicated urinary
Acid resistant: Yes tract and upper respiratory tract infections
Plasma Protein Binding: 8-17% caused by
B-Lactamase Resistance: Poor susceptible organisms
Spectrum of activity: Broad
Antipseudomonal Activity: No
Is the only cephalosporin derivative available in
both oral and parenteral dosage forms. It closely
resembles cephalexin chemically (it maybe
regarded as a partially hydrogenated derivative of
cephalexin) and has very similar antibacterial and
pharmacokinetic properties.
It occurs as a crystalline hydrate that is readily
soluble in water. Cephradine is stable to acid and
absorbed almost completely after oral
administration. It is minimally protein bound and
excreted almost exclusively through the kidneys.
Cefadroxil DURICEF) 1st generation
ROA: Oral
Acid resistant: Yes
Plasma Protein Binding: 20%
B-Lactamase Resistance: Poor
Spectrum of activity: Broad
Antipseudomonal Activity: No